Gad Cotter, Benjamin Deniau, Beth Davison, Christopher Edwards, Marianna Adamo, Mattia Arrigo, Marianela Barros, Jan Biegus, Jelena Celutkiene, Kamile Cerlinskaite-Bajore, Ovidiu Chioncel, Alain Cohen-Solal, Albertino Damasceno, Rafael Diaz, Gerasimos Filippatos, Etienne Gayat, Antoine Kimmoun, Carolyn S P Lam, Marco Metra, Maria Novosadova, Peter S Pang, Matteo Pagnesi, Piotr Ponikowski, Hadiza Saidu, Karen Sliwa, Koji Takagi, Jozine M Ter Maaten, Daniela Tomasoni, Adriaan Voors, Alexandre Mebazaa
IMPORTANCE: The Safety, Tolerability, and Efficacy of Rapid Optimization, Helped by N-Terminal Pro-Brain Natriuretic Peptide Testing of Heart Failure Therapies (STRONG-HF) trial strived for rapid uptitration aiming to reach 100% optimal doses of guideline-directed medical therapy (GDMT) within 2 weeks after discharge from an acute heart failure (AHF) admission. OBJECTIVE: To assess the association between degree of GDMT doses achieved in high-intensity care and outcomes...
December 27, 2023: JAMA Cardiology